Integra buys NMT neuroscience line for $12 million
This article was originally published in Clinica
Integra LifeSciences is to buy various parts of NMT Medical's neurosciences business for $12 million in cash. The move allows NMT to concentrate on its core cardiac business.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.